“寿险头雁”中国人寿拟出资40亿元参设私募基金 聚焦人工智能等领域
Hua Er Jie Jian Wen·2026-01-23 11:33

Core Viewpoint - China Life Insurance Company is expanding its investment strategy by establishing a partnership to invest in strategic emerging industries, particularly in artificial intelligence, integrated circuits, and biomedicine [1][2]. Group 1: Partnership Structure and Investment Amount - The total committed capital for the partnership is 5.0515 billion yuan, with China Life contributing 4 billion yuan [2]. - The management structure will be led by Guoshou Capital, which will act as the manager of the partnership [2]. Group 2: Investment Strategy and Duration - The partnership will have a duration of ten years from the date of the first business license issuance, with an initial investment period of five years followed by a five-year exit period [2]. - At least 70% of the investment will be allocated to the artificial intelligence sector [2]. Group 3: Governance Structure - The partnership will establish an investment decision committee and an investment advisory committee, with specific member allocations from the involved parties [2]. Group 4: Related Party Transactions - The transaction is classified as a related party transaction under the listing rules, as China Life is the controlling shareholder of Guoshou Capital and has subsidiaries involved in the partnership [2][3]. Group 5: Exit Strategy and Historical Success - Guoshou Asset has a successful track record in alternative investments, exemplified by the recent successful exit through the restructuring of Guodian Power Nuclear Company, marking a significant achievement in its investment management capabilities [3].

China Life-“寿险头雁”中国人寿拟出资40亿元参设私募基金 聚焦人工智能等领域 - Reportify